These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3504513)

  • 1. Adriamycin-loaded niosomes: drug entrapment, stability and release.
    Rogerson A; Cummings J; Florence AT
    J Microencapsul; 1987; 4(4):321-8. PubMed ID: 3504513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
    Manosroi A; Jantrawut P; Manosroi J
    Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adriamycin entrapped by sulfatide-containing liposomes on ovarian tumor-bearing nude mice.
    Kojima N; Ueno N; Takano M; Yabushita H; Noguchi M; Ishihara M; Yagi K
    Biotechnol Appl Biochem; 1986 Oct; 8(5):471-8. PubMed ID: 3768148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the preparation of camptothecin niosomes].
    Luan LB; Zhu JB; Yu WP; Wei KB
    Yao Xue Xue Bao; 2002 Jan; 37(1):59-62. PubMed ID: 12579902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer.
    Paolino D; Cosco D; Muzzalupo R; Trapasso E; Picci N; Fresta M
    Int J Pharm; 2008 Apr; 353(1-2):233-42. PubMed ID: 18191509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
    Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J
    Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
    J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
    Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
    Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of niosomes containing rifampicin for lung targeting.
    Jain CP; Vyas SP
    J Microencapsul; 1995; 12(4):401-7. PubMed ID: 8583314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.
    Vyas SP; Singh RP; Jain S; Mishra V; Mahor S; Singh P; Gupta PN; Rawat A; Dubey P
    Int J Pharm; 2005 May; 296(1-2):80-6. PubMed ID: 15885458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of naftifine hydrochloride alcohol-free niosome gel.
    Barakat HS; Darwish IA; El-Khordagui LK; Khalafallah NM
    Drug Dev Ind Pharm; 2009 May; 35(5):631-7. PubMed ID: 18989805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of niosomes and polysorbate 80 on the metabolism and excretion of methotrexate in the mouse.
    Azmin MN; Florence AT; Handjani-Vila RM; Stuart JF; Vanlerberghe G; Whittaker JS
    J Microencapsul; 1986; 3(2):95-100. PubMed ID: 3508183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
    Pardakhty A; Varshosaz J; Rouholamini A
    Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies.
    Sihorkar V; Vyas SP
    Pharmazie; 2000 Feb; 55(2):107-13. PubMed ID: 10723768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
    Mayer LD; Tai LC; Ko DS; Masin D; Ginsberg RS; Cullis PR; Bally MB
    Cancer Res; 1989 Nov; 49(21):5922-30. PubMed ID: 2790807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of niosome encapsulated insulin.
    Khaksa G; D'Souza R; Lewis S; Udupa N
    Indian J Exp Biol; 2000 Sep; 38(9):901-5. PubMed ID: 12561948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
    Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
    Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of EP-liposomes and Span 40-niosomes.
    Ning M; Guo Y; Pan H; Zong S; Gu Z
    Pharmazie; 2006 Mar; 61(3):208-12. PubMed ID: 16599261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.